XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.26.1

Acquisitions and Disposals | 3 Months Ended
--- | ---
Mar. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] |
Acquisitions and Disposals | Acquisitions and Disposals Acquisition of Pathline, LLC On April 4, 2025 (the “Pathline Acquisition Date”), the Company completed the acquisition of a 100% ownership interest in Pathline LLC (“Pathline”), a CLIA/CAP/NYS-certified laboratory based in New Jersey. The purchase price consisted of (i) gross initial consideration of $8.0 million, which was reduced by a net adjustment of $0.7 million reflective of cash and other adjustments and (ii) up to $2.0 million of contingent consideration if Pathline completes certain validation milestones within a specific timeline. As of the Pathline Acquisition Date, the Company estimated the contingent consideration liability to be $1.0 million, reflecting its best estimate regarding the achievement of the validation milestone. In September 2025, the Company met the contingent consideration threshold of $1.0 million upon achievement of the validation milestone. The Pathline acquisition aligns with the Company's strategic objective of expanding its presence, capabilities, and offerings in the Northeastern United States. The acquisition of Pathline was determined to be a business combination and has been accounted for using the acquisition method. The purchase price and purchase price allocation were based upon management’s best estimates and assumptions and were considered final as of March 31, 2026. The following table summarizes the purchase consideration recorded for the acquisition of Pathline, the fair value of the net assets acquired and liabilities assumed, and the calculation of goodwill based on the excess of the consideration transferred over the fair value of the net assets acquired and liabilities assumed at the Pathline Acquisition Date (in thousands, except per share data):
|  | April 4, 2025 (as initially reported) |  | Measurement Period Adjustments |  | April 4, 2025 (as adjusted)
Purchase consideration: |  |  |  |  |  |
Initial cash consideration, net(1) |  | $ | 7,275 |  |  | $ | 220 |  |  | $ | 7,495 |
Contingent consideration |  | 1,000 |  |  | — |  |  | 1,000 |
Total purchase consideration |  | $ | 8,275 |  |  | $ | 220 |  |  | $ | 8,495 |
Allocation of the purchase consideration: |  |  |  |  |  |
Cash and cash equivalents |  | $ | 317 |  |  | $ | — |  |  | $ | 317 |
Accounts receivable, net |  | 3,324 |  |  | — |  |  | 3,324 |
Inventories |  | 657 |  |  | — |  |  | 657 |
Prepaid and other current assets |  | 443 |  |  | 234 |  |  | 677 |
Intangible assets |  | 1,200 |  |  | — |  |  | 1,200 |
Property and equipment |  | 1,264 |  |  | — |  |  | 1,264 |
Operating lease right-of-use assets |  | 6,632 |  |  | (161) |  |  | 6,471 |
Other non-current assets |  | 200 |  |  | — |  |  | 200 |
Total identifiable assets acquired |  | 14,037 |  |  | 73 |  |  | 14,110 |
Total identifiable liabilities assumed |  | 10,602 |  |  | (258) |  |  | 10,344 |
Net identifiable assets acquired |  | 3,435 |  |  | 331 |  |  | 3,766 |
Goodwill(2) |  | 4,840 |  |  | (111) |  |  | 4,729 |
Total purchase consideration |  | $ | 8,275 |  |  | $ | 220 |  |  | $ | 8,495 |
_________________ (1) Includes net adjustments of $0.7 million reflective of cash and other adjustments as initially reported, and $0.5 million reflective of cash and other adjustments as adjusted. (2) Includes measurement period adjustments of negative $0.3 million recognized during the three months ended March 31, 2026 and $0.2 million recognized during the year ended December 31, 2025. The goodwill recognized was primarily attributable to expected synergies of the combined businesses, increased market penetration, and expanded service capabilities in the Northeast resulting from the acquisition. A majority of the goodwill resulting from the acquisition of Pathline is expected to be deductible for income tax purposes. Acquired intangible assets consist of customer relationships, which were valued using an income-based approach by discounting expected cash flows from existing customer relationships to determine the economic benefit expected to be realized post-acquisition. These assets will be amortized over a weighted average period of seven years. Sale of Trapelo Health, LLC On December 31, 2025, the Company completed the sale of substantially all of the operating assets of Trapelo Health, LLC (“Trapelo”), its wholly owned subsidiary, for upfront consideration of $2.5 million and contingent consideration of up to $5.0 million upon achievement of certain revenue milestones within a specified period. During the three months ended March 31, 2026, there were no changes to the Company's estimate of contingent consideration. During 2025, the Company recognized total impairment charges of $15.9 million related to the Trapelo disposal group, consisting of a $3.5 million loss on goodwill and a $12.4 million loss on developed technology, which were included within impairment charges on the Consolidated Statements of Operations. There were no impairment charges related to Trapelo during the three months ended March 31, 2026 and December 31, 2025.

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationAndAssetAcquisitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/205-20/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/805/tableOfContent + Details
Name: | us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration